Newly diagnosed glioblastoma: A review on clinical management

Research output: Contribution to journalReview article

19 Scopus citations

Abstract

Glioblastoma is an aggressive primary tumor of the central nervous system. This review will focus on clinical developments and management of newly diagnosed disease, including a discussion about the incorporation of molecular features into the classifi cation of glioblastoma. Such advances will continue to shape our thinking about the disease and how to best manage it. With regards to treatment, the role of surgical resection, radiotherapy, chemotherapy, and tumortreating fi elds will be presented. Pivotal studies defi ning our current standard of care will be highlighted, as will key ongoing trials that may infl uence our management of glioblastoma in the near future.

Original languageEnglish (US)
Pages (from-to)91-100
Number of pages10
JournalONCOLOGY (United States)
Volume33
Issue number3
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Newly diagnosed glioblastoma: A review on clinical management'. Together they form a unique fingerprint.

  • Cite this